Abstract
In this chapter, the emerging concept is discussed holding that the induction of immune tolerance is preferentially promoted by tolerogenic dendritic cells and regulatory T cells in situations where DAMPs are not present. In the first subchapter, the phenomenon of central T cell tolerance induced in the thymus is examined more carefully. The elimination of potentially dangerous self-reacting thymocytes is especially described by highlighting the mechanisms of clonal deletion/negative selection and clonal diversion that is mediated by thymic tolerogenic dendritic cells. These thymic DCs are involved in the creation of central tolerance via selection of thymic regulatory T cells.
Two subsequent subchapters are dedicated to the phenomenon of peripheral T cell tolerance which is induced by intrinsic mechanisms including processes of dendritic cell-mediated induction of T cell anergy and peripheral T cell deletion, as well as extrinsic mechanisms that refer to peripheral tolerogenic dendritic cell-mediated regulation of autoreactive T cells, mainly via generation of peripherally derived antigen-specific regulatory Foxp3+ T cells. This subset of T cells can suppress those lymphocytes reactive against (1) self antigens which have escaped central tolerance mechanisms in the thymus as well as (2) vital “life-protective” nonself antigens (e.g., dietary or commensal antigens) which do not exist in the thymus. Finally, particular attention is drawn to means and methods suitable to induce in vivo and/or in vitro human regulatory T cells. These efforts have led to some clinical trials to test the safety and efficacy of these immunosuppression-mediating cells in transplant patients or patients suffering from immunological disorders such as autoimmune diseases.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Starr TK, Jameson SC, Hogquist KA. Positive and negative selection of T cells. Annu Rev Immunol. 2003;21:139–76. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12414722
Josefowicz SZ, Lu L-F, Rudensky AY. Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol. 2012;30:531–64. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22224781
Xing Y, Hogquist KA. T-cell tolerance: central and peripheral. Cold Spring Harb Perspect Biol. 2012;4:a006957. https://doi.org/10.1101/cshperspect.a006957.
Benoist C, Mathis D. Treg cells, life history, and diversity. Cold Spring Harb Perspect Biol. 2012;4:a007021. https://doi.org/10.1101/cshperspect.a007021.
Oh J, Shin J-S. The role of dendritic cells in central tolerance. Immune Netw. 2015;15:111–20. https://doi.org/10.4110/in.2015.15.3.111.
Yamano T, Steinert M, Klein L. Thymic B cells and central T cell tolerance. Front Immunol. 2015;6:376. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26257742
Cowan JE, Jenkinson WE, Anderson G. Thymus medulla fosters generation of natural Treg cells, invariant γδ T cells, and invariant NKT cells: what we learn from intrathymic migration. Eur J Immunol. 2015;45:652–60. https://doi.org/10.1002/eji.201445108.
Perry JSA, Lio C-WJ, Kau AL, Nutsch K, Yang Z, Gordon JI, et al. Distinct contributions of Aire and antigen-presenting-cell subsets to the generation of self-tolerance in the thymus. Immunity. 2014;41:414–26. Available from: http://linkinghub.elsevier.com/retrieve/pii/S107476131400301X
Akiyama T, Tateishi R, Akiyama N, Yoshinaga R, Kobayashi TJ. Positive and negative regulatory mechanisms for fine-tuning cellularity and functions of medullary thymic epithelial cells. Front Immunol. 2015;6:461. Available from: http://journal.frontiersin.org/Article/10.3389/fimmu.2015.00461/abstract
Lopes N, Sergé A, Ferrier P, Irla M. Thymic crosstalk coordinates medulla organization and T-cell tolerance induction. Front Immunol. 2015;6:365. Available from: http://journal.frontiersin.org/Article/10.3389/fimmu.2015.00365/abstract
Passos GA, Mendes-da-Cruz DA, Oliveira EH. The Thymic orchestration involving Aire, miRNAs, and cell-cell interactions during the induction of central tolerance. Front Immunol. 2015;6:352. Available from: http://journal.frontiersin.org/Article/10.3389/fimmu.2015.00352/abstract
Abramson J, Goldfarb Y. AIRE: from promiscuous molecular partnerships to promiscuous gene expression. Eur J Immunol. 2016;46:22–33. https://doi.org/10.1002/eji.201545792.
Anderson MS, Su MA. AIRE expands: new roles in immune tolerance and beyond. Nat Rev Immunol. 2016;16:247–58. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26972725
Gallegos AM, Bevan MJ. Central tolerance to tissue-specific antigens mediated by direct and indirect antigen presentation. J Exp Med. 2004;200:1039–49. https://doi.org/10.1084/jem.20041457.
Aichinger M, Wu C, Nedjic J, Klein L. Macroautophagy substrates are loaded onto MHC class II of medullary thymic epithelial cells for central tolerance. J Exp Med. 2013;210:287–300. https://doi.org/10.1084/jem.20122149.
Wu L, Shortman K. Heterogeneity of thymic dendritic cells. Semin Immunol. 2005;17:304–12. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1044532305000394
Thornton AM, Korty PE, Tran DQ, Wohlfert EA, Murray PE, Belkaid Y, et al. Expression of helios, an ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells. J Immunol. 2010;184:3433–41. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20181882
Weiss JM, Bilate AM, Gobert M, Ding Y, Curotto de Lafaille MA, Parkhurst CN, et al. Neuropilin 1 is expressed on thymus-derived natural regulatory T cells, but not mucosa-generated induced Foxp3 + T reg cells. J Exp Med. 2012;209:1723–42. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22966001
Yadav M, Louvet C, Davini D, Gardner JM, Martinez-Llordella M, Bailey-Bucktrout S, et al. Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo. J Exp Med. 2012;209:1713–22., S1-19. https://doi.org/10.1084/jem.20120822.
Shevach EM. Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity. 2009;30:636–45. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1074761309001976
Caramalho Í, Nunes-Cabaço H, Foxall RB, Sousa AE. Regulatory T-cell development in the human thymus. Front Immunol. 2015;6:395. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26284077
Bour-Jordan H, Esensten JH, Martinez-Llordella M, Penaranda C, Stumpf M, Bluestone JA. Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28/ B7 family. Immunol Rev. 2011;241:180–205. https://doi.org/10.1111/j.1600-065X.2011.01011.x.
Pletinckx K, Döhler A, Pavlovic V, Lutz MB. Role of dendritic cell maturity/costimulation for generation, homeostasis, and suppressive activity of regulatory T cells. Front Immunol. 2011;2:39. Available from: http://journal.frontiersin.org/article/10.3389/fimmu.2011.00039/abstract
Probst HC, Muth S, Schild H. Regulation of the tolerogenic function of steady-state DCs. Eur J Immunol. 2014;44:927–33. https://doi.org/10.1002/eji.201343862.
Gordon JR, Ma Y, Churchman L, Gordon SA, Dawicki W. Regulatory dendritic cells for immunotherapy in immunologic diseases. Front Immunol. 2014;5:7. Available from: http://journal.frontiersin.org/article/10.3389/fimmu.2014.00007/abstract
Lutz MB. Induction of CD4(+) regulatory and polarized effector/helper T cells by dendritic cells. Immune Netw. 2016;16:13–25. https://doi.org/10.4110/in.2016.16.1.13.
Takenaka MC, Quintana FJ. Tolerogenic dendritic cells. Semin Immunopathol. 2017;39:113–20. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27646959
Suffner J, Hochweller K, Kühnle M-C, Li X, Kroczek RA, Garbi N, et al. Dendritic cells support homeostatic expansion of Foxp3+ regulatory T cells in Foxp3.LuciDTR mice. J Immunol. 2010;184:1810–20. https://doi.org/10.4049/jimmunol.0902420.
Morelli AE, Thomson AW. Tolerogenic dendritic cells and the quest for transplant tolerance. Nat Rev Immunol. 2007;7:610–21. https://doi.org/10.1038/nri2132.
Manicassamy S, Pulendran B. Dendritic cell control of tolerogenic responses. Immunol Rev. 2011;241:206–27. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21488899
Lutz MB. Therapeutic potential of semi-mature dendritic cells for tolerance induction. Front Immunol. 2012;3:123. Available from: http://journal.frontiersin.org/article/10.3389/fimmu.2012.00123/abstract
Dudek AM, Martin S, Garg AD, Agostinis P. Immature, semi-mature, and fully mature dendritic cells: toward a DC-Cancer cells Interface that augments anticancer immunity. Front Immunol. 2013;4:438. Available from: http://journal.frontiersin.org/article/10.3389/fimmu.2013.00438/abstract
Raker VK, Domogalla MP, Steinbrink K. Tolerogenic dendritic cells for regulatory T cell induction in man. Front Immunol. 2015;6:569. Available from: http://journal.frontiersin.org/Article/10.3389/fimmu.2015.00569/abstract
Yoo S, Ha S-J. Generation of tolerogenic dendritic cells and their therapeutic applications. Immune Netw. 2016;16:52–60. https://doi.org/10.4110/in.2016.16.1.52.
Hubo M, Trinschek B, Kryczanowsky F, Tuettenberg A, Steinbrink K, Jonuleit H. Costimulatory molecules on immunogenic versus tolerogenic human dendritic cells. Front Immunol. 2013;4:82. Available from: http://journal.frontiersin.org/article/10.3389/fimmu.2013.00082/abstract
Hawiger D, Inaba K, Dorsett Y, Guo M, Mahnke K, Rivera M, et al. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med. 2001;194:769–79. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11560993
Bonifaz L, Bonnyay D, Mahnke K, Rivera M, Nussenzweig MC, Steinman RM. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. J Exp Med. 2002;196:1627–38. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12486105
Probst HC, Lagnel J, Kollias G, van den Broek M. Inducible transgenic mice reveal resting dendritic cells as potent inducers of CD8+ T cell tolerance. Immunity. 2003;18:713–20. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12753747
Probst HC, McCoy K, Okazaki T, Honjo T, van den Broek M. Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4. Nat Immunol. 2005;6:280–6. https://doi.org/10.1038/ni1165.
Mellor AL, Munn DH. Ido expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol. 2004;4:762–74. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15459668
Belladonna ML, Grohmann U, Guidetti P, Volpi C, Bianchi R, Fioretti MC, et al. Kynurenine pathway enzymes in dendritic cells initiate tolerogenesis in the absence of functional IDO. J Immunol. 2006;177:130–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16785507
Pallotta MT, Orabona C, Volpi C, Vacca C, Belladonna ML, Bianchi R, et al. Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells. Nat Immunol. 2011;12:870–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21804557
Wang Y, Yang B-H, Li H, Cao S, Ren X-B, Yu J-P. IDO+ DCs and signalling pathways. Curr Cancer Drug Targets. 2013;13:278–88. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23369095
Darrasse-Jèze G, Deroubaix S, Mouquet H, Victora GD, Eisenreich T, Yao K, et al. Feedback control of regulatory T cell homeostasis by dendritic cells in vivo. J Exp Med. 2009;206:1853–62. https://doi.org/10.1084/jem.20090746.
Bar-On L, Birnberg T, Kim K, Jung S. Dendritic cell-restricted CD80/86 deficiency results in peripheral regulatory T-cell reduction but is not associated with lymphocyte hyperactivation. Eur J Immunol. 2011;41:291–8. https://doi.org/10.1002/eji.201041169.
Bakdash G, Sittig SP, van Dijk T, Figdor CG, de Vries IJM. The nature of activatory and tolerogenic dendritic cell-derived signal II. Front Immunol. 2013;4:53. Available from: http://journal.frontiersin.org/article/10.3389/fimmu.2013.00053/abstract
Tuettenberg A, Fondel S, Steinbrink K, Enk AH, Jonuleit H. CD40 signalling induces IL-10-producing, tolerogenic dendritic cells. Exp Dermatol. 2010;19:44–53. https://doi.org/10.1111/j.1600-0625.2009.00975.x.
Ishii N, Takahashi T, Soroosh P, Sugamura K. OX40-OX40 ligand interaction in T-cell-mediated immunity and immunopathology. Adv Immunol. 2010;105:63–98. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0065277610050030
Herman AE, Freeman GJ, Mathis D, Benoist C. CD4+CD25+ T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion. J Exp Med. 2004;199:1479–89. https://doi.org/10.1084/jem.20040179.
Burmeister Y, Lischke T, Dahler AC, Mages HW, Lam K-P, Coyle AJ, et al. ICOS controls the pool size of effector-memory and regulatory T cells. J Immunol. 2008;180:774–82. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18178815
Busse M, Krech M, Meyer-Bahlburg A, Hennig C, Hansen G. ICOS mediates the generation and function of CD4+CD25+Foxp3+ regulatory T cells conveying respiratory tolerance. J Immunol. 2012;189:1975–82. https://doi.org/10.4049/jimmunol.1103581.
Fu F, Li Y, Qian S, Lu L, Chambers F, Starzl TE, et al. Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients. Transplantation. 1996;62:659–65. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8830833
Voigtländer C, Rössner S, Cierpka E, Theiner G, Wiethe C, Menges M, et al. Dendritic cells matured with TNF can be further activated in vitro and after subcutaneous injection in vivo which converts their tolerogenicity into immunogenicity. J Immunother. 2006;29:407–15. Available from: http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00002371-200607000-00007
Lutz MB, Schuler G. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol. 2002;23:445–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12200066
Reis e Sousa C. Dendritic cells in a mature age. Nat Rev Immunol. 2006;6:476–83. https://doi.org/10.1038/nri1845.
MacDonald AS, Maizels RM. Alarming dendritic cells for Th2 induction. J Exp Med. 2008;205:13–7. https://doi.org/10.1084/jem.20072665.
Yamazaki S, Bonito AJ, Spisek R, Dhodapkar M, Inaba K, Steinman RM. Dendritic cells are specialized accessory cells along with TGF- for the differentiation of Foxp3+ CD4+ regulatory T cells from peripheral Foxp3 precursors. Blood. 2007;110:4293–302. https://doi.org/10.1182/blood-2007-05-088831.
Ni L, Dong C. New B7 family checkpoints in human cancers. Mol Cancer Ther. 2017;16:1203–11. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28679835
Granier C, De Guillebon E, Blanc C, Roussel H, Badoual C, Colin E, et al. Mechanisms of action and rationale for the use of checkpoint inhibitors in cancer. ESMO Open. 2017;2:e000213. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28761757
Carreno BM, Bennett F, Chau TA, Ling V, Luxenberg D, Jussif J, et al. CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression. J Immunol. 2000;165:1352–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10903737
Rudd CE, Taylor A, Schneider H. CD28 and CTLA-4 coreceptor expression and signal transduction. Immunol Rev. 2009;229:12–26. https://doi.org/10.1111/j.1600-065X.2009.00770.x.
Fallarino F, Grohmann U, Hwang KW, Orabona C, Vacca C, Bianchi R, et al. Modulation of tryptophan catabolism by regulatory T cells. Nat Immunol. 2003;4:1206–12. https://doi.org/10.1038/ni1003.
Qureshi OS, Zheng Y, Nakamura K, Attridge K, Manzotti C, Schmidt EM, et al. Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4. Science. 2011;332:600–3. https://doi.org/10.1126/science.1202947.
Dilek N, Poirier N, Hulin P, Coulon F, Mary C, Ville S, et al. Targeting CD28, CTLA-4 and PD-L1 costimulation differentially controls immune synapses and function of human regulatory and conventional T-cells. PLoS One. 2013;8:e83139. https://doi.org/10.1371/journal.pone.0083139.
Agata Y, Kawasaki A, Nishimura H, Ishida Y, Tsubata T, Yagita H, et al. Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. Int Immunol. 1996;8:765–72. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8671665
Dong H, Zhu G, Tamada K, Chen L. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat Med. 1999;5:1365–9. https://doi.org/10.1038/70932.
Latchman Y, Wood CR, Chernova T, Chaudhary D, Borde M, Chernova I, et al. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat Immunol. 2001;2:261–8. https://doi.org/10.1038/85330.
Yamazaki T, Akiba H, Iwai H, Matsuda H, Aoki M, Tanno Y, et al. Expression of programmed death 1 ligands by murine T cells and APC. J Immunol. 2002;169:5538–45. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12421930
Greenwald RJ, Freeman GJ, Sharpe AH. The B7 family revisited. Annu Rev Immunol. 2005;23:515–48. https://doi.org/10.1146/annurev.immunol.23.021704.115611.
Zhong X, Tumang JR, Gao W, Bai C, Rothstein TL. PD-L2 expression extends beyond dendritic cells/macrophages to B1 cells enriched for V(H)11/V(H)12 and phosphatidylcholine binding. Eur J Immunol. 2007;37:2405–10. https://doi.org/10.1002/eji.200737461.
Butte MJ, Keir ME, Phamduy TB, Sharpe AH, Freeman GJ. Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses. Immunity. 2007;27:111–22. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1074761307003287
Sharpe AH, Wherry EJ, Ahmed R, Freeman GJ. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat Immunol. 2007;8:239–45. https://doi.org/10.1038/ni1443.
Riley JL. PD-1 signaling in primary T cells. Immunol Rev. 2009;229:114–25. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19426218
Pauken KE, Wherry EJ. SnapShot: T cell exhaustion. Cell. 2015;163:1038–1038.e1. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0092867415014105
Wei F, Zhong S, Ma Z, Kong H, Medvec A, Ahmed R, et al. Strength of PD-1 signaling differentially affects T-cell effector functions. Proc Natl Acad Sci U S A. 2013;110:E2480–9. https://doi.org/10.1073/pnas.1305394110.
Francisco LM, Salinas VH, Brown KE, Vanguri VK, Freeman GJ, Kuchroo VK, et al. PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. J Exp Med. 2009;206:3015–29. https://doi.org/10.1084/jem.20090847.
Francisco LM, Sage PT, Sharpe AH. The PD-1 pathway in tolerance and autoimmunity. Immunol Rev. 2010;236:219–42. https://doi.org/10.1111/j.1600-065X.2010.00923.x.
Gabryšová L, Howes A, Saraiva M, O’Garra A. The regulation of IL-10 expression. Curr Top Microbiol Immunol. 2014;380:157–90. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25004818
Johnston PA, Grandis JR. STAT3 signaling: anticancer strategies and challenges. Mol Interv. 2011;11:18–26. https://doi.org/10.1124/mi.11.1.4.
Li HS, Watowich SS. Innate immune regulation by STAT-mediated transcriptional mechanisms. Immunol Rev. 2014;261:84–101. https://doi.org/10.1111/imr.12198.
Rizzuti D, Ang M, Sokollik C, Wu T, Abdullah M, Greenfield L, et al. Helicobacter pylori inhibits dendritic cell maturation via interleukin-10-mediated activation of the signal transducer and activator of transcription 3 pathway. J Innate Immun. 2015;7:199–211. https://doi.org/10.1159/000368232.
Amodio G, Gregori S. Human tolerogenic DC-10: perspectives for clinical applications. Transplant Res. 2012;1:14. https://doi.org/10.1186/2047-1440-1-14.
Dixon KO, van der Kooij SW, Vignali DAA, van Kooten C. Human tolerogenic dendritic cells produce IL-35 in the absence of other IL-12 family members. Eur J Immunol. 2015;45:1736–47. https://doi.org/10.1002/eji.201445217.
Land WG. How evolution tells us to induce allotolerance. Exp Clin Transplant. 2015;13(Suppl 1):46–54. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25894127
Kretschmer K, Apostolou I, Hawiger D, Khazaie K, Nussenzweig MC, von Boehmer H. Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol. 2005;6:1219–27. https://doi.org/10.1038/ni1265.
Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T Cells and immune tolerance. Cell. 2008;133:775–87. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18510923
Feuerer M, Hill JA, Mathis D, Benoist C. Foxp3+ regulatory T cells: differentiation, specification, subphenotypes. Nat Immunol. 2009;10:689–95. https://doi.org/10.1038/ni.1760.
Rudensky AY. Regulatory T Cells and Foxp3. Immunol Rev. 2011;241:260–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21488902
Kosten IJ, Rustemeyer T. Generation, subsets and functions of inducible regulatory T cells. Antiinflamm Antiallergy Agents Med Chem. 2015;13:139–53. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25427312
Perdigoto AL, Chatenoud L, Bluestone JA, Herold KC. Inducing and administering Tregs to treat human disease. Front Immunol. 2015;6:654. Available from: http://journal.frontiersin.org/Article/10.3389/fimmu.2015.00654/abstract
Shevach EM, Thornton AM. tTregs, pTregs, and iTregs: similarities and differences. Immunol Rev. 2014;259:88–102. https://doi.org/10.1111/imr.12160.
Lathrop SK, Bloom SM, Rao SM, Nutsch K, Lio C-W, Santacruz N, et al. Peripheral education of the immune system by colonic commensal microbiota. Nature. 2011;478:250–4. https://doi.org/10.1038/nature10434.
Nutsch KM, Hsieh C-S. T cell tolerance and immunity to commensal bacteria. Curr Opin Immunol. 2012;24:385–91. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22613090
Jiang TT, Chaturvedi V, Ertelt JM, Kinder JM, Clark DR, Valent AM, et al. Regulatory T cells: new keys for further unlocking the enigma of fetal tolerance and pregnancy complications. J Immunol. 2014;192:4949–56. https://doi.org/10.4049/jimmunol.1400498.
Svensson-Arvelund J, Mehta RB, Lindau R, Mirrasekhian E, Rodriguez-Martinez H, Berg G, et al. The human fetal placenta promotes tolerance against the semiallogeneic fetus by inducing regulatory T cells and homeostatic M2 macrophages. J Immunol. 2015;194:1534–44. https://doi.org/10.4049/jimmunol.1401536.
Clark DA. The importance of being a regulatory T cell in pregnancy. J Reprod Immunol. 2016;116:60–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27219894
Kim KS, Surh CD. Induction of immune tolerance to dietary antigens. Adv Exp Med Biol. 2015;850:93–118. https://doi.org/10.1007/978-3-319-15774-0_8.
Berin MC, Shreffler WG. Mechanisms underlying induction of tolerance to foods. Immunol Allergy Clin N Am. 2016;36:87–102. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0889856115000661
Wawrzyniak M, O’Mahony L, Akdis M. Role of regulatory cells in oral tolerance. Allergy Asthma Immunol Res. 2017;9:107. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28102055
Bluestone JA, Trotta E, Xu D. The therapeutic potential of regulatory T cells for the treatment of autoimmune disease. Expert Opin Ther Targets. 2015;19:1091–103. https://doi.org/10.1517/14728222.2015.1037282.
Roncarolo MG, Gregori S, Bacchetta R, Battaglia M. Tr1 cells and the counter-regulation of immunity: natural mechanisms and therapeutic applications. Curr Top Microbiol Immunol. 2014;380:39–68. https://doi.org/10.1007/978-3-662-43492-5_3.
Zeng H, Zhang R, Jin B, Chen L. Type 1 regulatory T cells: a new mechanism of peripheral immune tolerance. Cell Mol Immunol. 2015;12:566–71. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26051475
Kushwah R, Hu J. Role of dendritic cells in the induction of regulatory T cells. Cell Biosci. 2011;1:20. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21711933
Chen Y, Kuchroo VK, Inobe J, Hafler DA, Weiner HL. Regulatory T Cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science. 1994;265:1237–40. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7520605
Kuhn C, Weiner HL. Immunology. How does the immune system tolerate food? Science. 2016;351:810–1. https://doi.org/10.1126/science.aaf2167.
Miller SD, Turley DM, Podojil JR. Antigen-specific tolerance strategies for the prevention and treatment of autoimmune disease. Nat Rev Immunol. 2007;7:665–77. https://doi.org/10.1038/nri2153.
McGinty JW, Chow I-T, Greenbaum C, Odegard J, Kwok WW, James EA. Recognition of posttranslationally modified GAD65 epitopes in subjects with type 1 diabetes. Diabetes. 2014;63:3033–40. https://doi.org/10.2337/db13-1952.
Rosen A, Casciola-Rosen L. Autoantigens as partners in initiation and propagation of autoimmune rheumatic diseases. Annu Rev Immunol. 2016;34:395–420. https://doi.org/10.1146/annurev-immunol-032414-112205.
Omenetti S, Pizarro TT. The Treg/Th17 axis: a dynamic balance regulated by the gut microbiome. Front Immunol. 2015;6:639. Available from: http://journal.frontiersin.org/Article/10.3389/fimmu.2015.00639/abstract
Dahlberg PE, Schartner JM, Timmel A, Seroogy CM. Daily subcutaneous injections of peptide induce CD4+ CD25+ T regulatory cells. Clin Exp Immunol. 2007;149:226–34. https://doi.org/10.1111/j.1365-2249.2007.03402.x.
von Boehmer H. Peptide-based instruction of suppressor commitment in naïve T cells and dynamics of immunosuppression in vivo. Scand J Immunol. 2005;62(Suppl 1):49–54. https://doi.org/10.1111/j.1365-3083.2005.01609.x.
Verginis P, McLaughlin KA, Wucherpfennig KW, von Boehmer H, Apostolou I. Induction of antigen-specific regulatory T cells in wild-type mice: visualization and targets of suppression. Proc Natl Acad Sci U S A. 2008;105:3479–84. https://doi.org/10.1073/pnas.0800149105.
Poloski E, Oettel A, Ehrentraut S, Luley L, Costa SD, Zenclussen AC, et al. JEG-3 trophoblast cells producing human chorionic gonadotropin promote conversion of human CD4+FOXP3- T cells into CD4+FOXP3+ regulatory T cells and Foster T cell suppressive activity. Biol Reprod. 2016;94:106. https://doi.org/10.1095/biolreprod.115.135541.
Ko H-J, Chang S-Y. Regulation of intestinal immune system by dendritic cells. Immune Netw. 2015;15:1–8. https://doi.org/10.4110/in.2015.15.1.1.
Esterházy D, Loschko J, London M, Jove V, Oliveira TY, Mucida D. Classical dendritic cells are required for dietary antigen-mediated induction of peripheral T(reg) cells and tolerance. Nat Immunol. 2016;17:545–55. https://doi.org/10.1038/ni.3408.
Chevalier N, Mueller M, Mougiakakos D, Ihorst G, Marks R, Schmitt-Graeff A, et al. Analysis of dendritic cell subpopulations in follicular lymphoma with respect to the tumor immune microenvironment. Leuk Lymphoma. 2016;57:2150–60. Available form: http://www.ncbi.nlm.nih.gov/pubmed/26757600
Hoeppli RE, Wu D, Cook L, Levings MK. The environment of regulatory T cell biology: cytokines, metabolites, and the microbiome. Front Immunol. 2015;6:61. Available form: http://journal.frontiersin.org/Article/10.3389/fimmu.2015.00061/abstract
Chen W, Jin W, Hardegen N, Lei K, Li L, Marinos N, et al. Conversion of peripheral CD4 + CD25 − naive T cells to CD4 + CD25 + regulatory T cells by TGF-β induction of transcription factor Foxp3. J Exp Med. 2003;198:1875–86. Available form: http://www.ncbi.nlm.nih.gov/pubmed/14676299
Floess S, Freyer J, Siewert C, Baron U, Olek S, Polansky J, et al. Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol. 2007;e38:5. https://doi.org/10.1371/journal.pbio.0050038.
DiPaolo RJ, Brinster C, Davidson TS, Andersson J, Glass D, Shevach EM. Autoantigen-specific TGFbeta-induced Foxp3+ regulatory T cells prevent autoimmunity by inhibiting dendritic cells from activating autoreactive T cells. J Immunol. 2007;179:4685–93. Available form: http://www.ncbi.nlm.nih.gov/pubmed/17878367
Hänig J, Lutz MB. Suppression of mature dendritic cell function by regulatory T cells in vivo is abrogated by CD40 licensing. J Immunol. 2008;180:1405–13. Available form: http://www.ncbi.nlm.nih.gov/pubmed/18209035
Wang YM, Ghali J, Zhang GY, Hu M, Wang Y, Sawyer A. Development and function of Foxp3 + regulatory T cells. Nephrology. 2016;21:81–5. Available form: http://www.ncbi.nlm.nih.gov/pubmed/26461175
Kitagawa Y, Ohkura N, Sakaguchi S. Molecular determinants of regulatory T cell development: the essential roles of epigenetic changes. Front Immunol. 2013;4:106. Available form: http://journal.frontiersin.org/article/10.3389/fimmu.2013.00106/abstract
Schmidt A, Eriksson M, Shang M-M, Weyd H, Tegnér J. Comparative analysis of protocols to induce human CD4+Foxp3+ regulatory T Cells by combinations of IL-2, TGF-beta, retinoic acid, rapamycin and butyrate. PLoS One. 2016;11:e0148474. https://doi.org/10.1371/journal.pone.0148474.
Schmitt N, Ueno H. Regulation of human helper T cell subset differentiation by cytokines. Curr Opin Immunol. 2015;34:130–6. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0952791515000552
Putnam AL, Brusko TM, Lee MR, Liu W, Szot GL, Ghosh T, et al. Expansion of human regulatory T-cells from patients with type 1 diabetes. Diabetes. 2009;58:652–62. https://doi.org/10.2337/db08-1168.
Kim JM, Rasmussen JP, Rudensky AY. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat Immunol. 2007;8:191–7. Available form: http://www.nature.com/doifinder/10.1038/ni1428
Schildknecht A, Brauer S, Brenner C, Lahl K, Schild H, Sparwasser T, et al. FoxP3+ regulatory T cells essentially contribute to peripheral CD8+ T-cell tolerance induced by steady-state dendritic cells. Proc Natl Acad Sci U S A. 2010;107:199–203. https://doi.org/10.1073/pnas.0910620107.
Noble A, Giorgini A, Leggat JA. Cytokine-induced IL-10-secreting CD8 T cells represent a phenotypically distinct suppressor T-cell lineage. Blood. 2006;107:4475–83. https://doi.org/10.1182/blood-2005-10-3994.
Zhang H, Kong H, Zeng X, Guo L, Sun X, He S. Subsets of regulatory T cells and their roles in allergy. J Transl Med. 2014;12:125. Available form: http://translational-medicine.biomedcentral.com/articles/10.1186/1479-5876-12-125
Siegmund K, Rückert B, Ouaked N, Bürgler S, Speiser A, Akdis CA, et al. Unique phenotype of human tonsillar and in vitro-induced FOXP3+CD8+ T cells. J Immunol. 2009;182:2124–30. https://doi.org/10.4049/jimmunol.0802271.
Kühl AA, Pawlowski NN, Grollich K, Blessenohl M, Westermann J, Zeitz M, et al. Human peripheral gammadelta T cells possess regulatory potential. Immunology. 2009;128:580–8. https://doi.org/10.1111/j.1365-2567.2009.03162.x.
Kabelitz D, Peters C, Wesch D, Oberg H-H. Regulatory functions of γδ T cells. Int Immunopharmacol. 2013;16:382–7. Available form: http://linkinghub.elsevier.com/retrieve/pii/S1567576913000398
Popko K, Górska E. The role of natural killer cells in pathogenesis of autoimmune diseases. Cent Eur J Immunol. 2015;4:470–6. Available form: http://www.ncbi.nlm.nih.gov/pubmed/26862312
Tard C, Rouxel O, Lehuen A. Regulatory role of natural killer T cells in diabetes. Biomed J. 2015;38:484–95. Available form: http://www.ncbi.nlm.nih.gov/pubmed/27013448
McEwen-Smith RM, Salio M, Cerundolo V. The regulatory role of invariant NKT cells in tumor immunity. Cancer Immunol Res. 2015;3:425–35. https://doi.org/10.1158/2326-6066.CIR-15-0062.
Chen J, Wu M, Wang J, Li X. Immunoregulation of NKT cells in systemic lupus erythematosus. J Immunol Res. 2015;2015:206731. Available form: http://www.hindawi.com/journals/jir/2015/206731/
Choi J, Suh B, Ahn Y-O, Kim TM, Lee J-O, Lee S-H, et al. CD15+/CD16low human granulocytes from terminal cancer patients: granulocytic myeloid-derived suppressor cells that have suppressive function. Tumour Biol. 2012;33:121–9. https://doi.org/10.1007/s13277-011-0254-6.
Marvel D, Gabrilovich DI. Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected. J Clin Invest. 2015;125:3356–64. Available form: http://www.jci.org/articles/view/80005
Motallebnezhad M, Jadidi-Niaragh F, Qamsari ES, Bagheri S, Gharibi T, Yousefi M. The immunobiology of myeloid-derived suppressor cells in cancer. Tumour Biol. 2016;37:1387–406. https://doi.org/10.1007/s13277-015-4477-9.
Damuzzo V, Pinton L, Desantis G, Solito S, Marigo I, Bronte V, et al. Complexity and challenges in defining myeloid-derived suppressor cells. Cytometry B Clin Cytom. 2015;88:77–91. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25504825
Matzinger P, Kamala T. Tissue-based class control: the other side of tolerance. Nat Rev Immunol. 2011;11:221–30. https://doi.org/10.1038/nri2940.
Brusko TM, Koya RC, Zhu S, Lee MR, Putnam AL, McClymont SA, et al. Human antigen-specific regulatory T cells generated by T cell receptor gene transfer. PLoS One. 2010;e11726:5. https://doi.org/10.1371/journal.pone.0011726.
Draghiciu O, Lubbers J, Nijman HW, Daemen T. Myeloid derived suppressor cells-an overview of combat strategies to increase immunotherapy efficacy. Oncoimmunology. 2015;4:e954829. https://doi.org/10.4161/21624011.2014.954829.
Rosenberg E, Zilber-Rosenberg I. Symbiosis and development: the hologenome concept. Birth Defects Res C Embryo Today Rev. 2011;93:56–66. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21425442
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Land, W.G. (2018). Antigen in the Absence of DAMPs Promotes Immune Tolerance: The Role of Dendritic Cells and Regulatory T Cells. In: Damage-Associated Molecular Patterns in Human Diseases. Springer, Cham. https://doi.org/10.1007/978-3-319-78655-1_33
Download citation
DOI: https://doi.org/10.1007/978-3-319-78655-1_33
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-78654-4
Online ISBN: 978-3-319-78655-1
eBook Packages: MedicineMedicine (R0)